Tumor-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules and related anti-cancer vaccine

Details for Australian Patent Application No. 2006289289 (hide)

Owner immatics biotechnologies GmbH

Inventors Weinschenk, Toni; Singh, Harpreet; Walter, Steffen; Emmerich, Niels

Agent Pizzeys

Pub. Number AU-B-2006289289

PCT Pub. Number WO2007/028573

Priority 05019255.8 05.09.05 EP

Filing date 5 September 2006

Wipo publication date 15 March 2007

Acceptance publication date 19 April 2012

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C12N 15/00 (2006.01) Mutation or genetic engineering

C12P 21/00 (2006.01) Preparation of peptides or proteins

Event Publications

13 March 2008 PCT application entered the National Phase

  PCT publication WO2007/028573 Priority application(s): WO2007/028573

28 April 2011 Alteration of Name

  The name of the applicant has been altered to immatics biotechnologies GmbH

19 April 2012 Application Accepted

  Published as AU-B-2006289289

16 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006289290-Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules

2006289285-Building system for constructing walls